I think the halt your referring to was for clarion clinics...

First 20016 Last

Share
Profile

Follow
Driver1

502 Posts.

78

25/07/24

11:16

Post #: 74910372
Share

Originally posted by flanostu: ↑

I'd like to better understand the patient recruitment for this trial. Still only five sites listed as "recruiting" but Joel said they've had to put a halt on patient recruitment due to robust levels already being met (for screening). This would basically meet the numbers required for the full Phase 2B trial as per Joel. Sounds great but is this for only those five sites or for all, or at least a good portion of? Perhaps the clinical register simply hasn't been updated to reflect this? My concern is that the US investors don't appear interested in this pivotal trial, well as yet.

I'm also indifferent as to how the US will view the Clarion patient numbers, largely because it's based in Oz. Still clueless how many are being treated, payment plans, healthcare insurers, expansion to other states, etc etc.

Hoping the numbers are great on both but we need an updated investor presentation. I can only assume our SP is reflective of peeps simply not knowing where the co. is at atm as the CEO hasn't come out & addressed our MC, or key issues highlighted by many.

I'm holding another biotech and their CEO is out & about doing investor presentations, keynote speaker events, investor webinars etc. She continually updates investors (and potential) on recruitment numbers, rationale for licensing agreements at various stages & jurisdictions etc. Be nice if we had the same as that SP is reflective of good management.

GLTAH

Expand

I think the halt your referring to was for clarion clinics intake.

IHL Price at posting: 4.1¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back

IPH

IPH raises $100M to buy up Canadian IP firm Bereskin & Parr

SER

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

NRX

Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt

The business of sport: Warren Tredrea's take on this week's news

Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions

RDN

Raiden gears up for exploration in final quarter of 2024

The Rising Tide: How institutional adoption is shaping the future of crypto

Reporting wrap: Inghams, Accent, Mayne Pharma

CC9

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

There are more pages in this discussion • 180 more messages in this thread...

First 20016 Last

Add IHL (ASX) to my watchlist

I think the halt your referring to was for clarion clinics...

Top Stories

Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back

IPH raises $100M to buy up Canadian IP firm Bereskin & Parr

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt

The business of sport: Warren Tredrea's take on this week's news

Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions

Raiden gears up for exploration in final quarter of 2024

The Rising Tide: How institutional adoption is shaping the future of crypto

Reporting wrap: Inghams, Accent, Mayne Pharma

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

Featured News